254 related articles for article (PubMed ID: 32892961)
1. The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.
Beversdorf DQ
Semin Pediatr Neurol; 2020 Oct; 35():100834. PubMed ID: 32892961
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder.
Hegarty JP; Ferguson BJ; Zamzow RM; Rohowetz LJ; Johnson JD; Christ SE; Beversdorf DQ
Brain Imaging Behav; 2017 Oct; 11(5):1278-1289. PubMed ID: 27714553
[TBL] [Abstract][Full Text] [Related]
3. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
Zamzow RM; Ferguson BJ; Stichter JP; Porges EC; Ragsdale AS; Lewis ML; Beversdorf DQ
Psychopharmacology (Berl); 2016 Apr; 233(7):1171-8. PubMed ID: 26762378
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers.
Zamzow RM; Ferguson BJ; Ragsdale AS; Lewis ML; Beversdorf DQ
J Clin Exp Neuropsychol; 2017 Aug; 39(6):596-606. PubMed ID: 27841098
[TBL] [Abstract][Full Text] [Related]
5. Autism Spectrum Disorder: Classification, diagnosis and therapy.
Sharma SR; Gonda X; Tarazi FI
Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacological interventions in autism spectrum disorder.
Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders.
Sagar-Ouriaghli I; Lievesley K; Santosh PJ
J Psychopharmacol; 2018 Jun; 32(6):641-653. PubMed ID: 29484909
[TBL] [Abstract][Full Text] [Related]
8. Effects of the Co-occurrence of Anxiety and Attention-Deficit/Hyperactivity Disorder on Intrinsic Functional Network Centrality among Children with Autism Spectrum Disorder.
Wan B; Wang Z; Jung M; Lu Y; He H; Chen Q; Jin Y
Autism Res; 2019 Jul; 12(7):1057-1068. PubMed ID: 31074587
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic targets for the treatment of alcohol use disorder.
Haass-Koffler CL; Swift RM; Leggio L
Psychopharmacology (Berl); 2018 Jun; 235(6):1625-1634. PubMed ID: 29460163
[TBL] [Abstract][Full Text] [Related]
10. Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
Manohar H; Kuppili PP; Kandasamy P; Chandrasekaran V; Rajkumar RP
Asian J Psychiatr; 2018 Mar; 33():68-73. PubMed ID: 29544110
[TBL] [Abstract][Full Text] [Related]
11. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder.
Beversdorf DQ; Ferguson B; Hunter S; Hirst K; Lolli B; Bellesheim KR; Barton AU; Muckerman J; Takahashi N; Selders K; Holem R; Sohl K; Dyke P; Stichter J; Mazurek M; Kanne S
Psychopharmacology (Berl); 2024 Jan; 241(1):19-32. PubMed ID: 38086927
[TBL] [Abstract][Full Text] [Related]
13. Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study.
Strazielle C; Lalonde R; Hébert C; Reader TA
Neuroscience; 1999; 94(1):287-304. PubMed ID: 10613519
[TBL] [Abstract][Full Text] [Related]
14.
Hegarty JP; Zamzow RM; Ferguson BJ; Christ SE; Porges EC; Johnson JD; Beversdorf DQ
Autism; 2020 Apr; 24(3):795-801. PubMed ID: 31416333
[No Abstract] [Full Text] [Related]
15. Language deficits in specific language impairment, attention deficit/hyperactivity disorder, and autism spectrum disorder: An analysis of polygenic risk.
Nudel R; Christiani CAJ; Ohland J; Uddin MJ; Hemager N; Ellersgaard DV; Spang KS; Burton BK; Greve AN; Gantriis DL; Bybjerg-Grauholm J; Jepsen JRM; Thorup AAE; Mors O; Nordentoft M; Werge T
Autism Res; 2020 Mar; 13(3):369-381. PubMed ID: 31577390
[TBL] [Abstract][Full Text] [Related]
16. Role of Noradrenergic Brain Nuclei in the Regulation of Carotid Artery Blood Flow: Pharmacological Evidence from Anesthetized Pigs with Alpha-2 Adrenergic Receptor Modulator Drugs.
Wirth KJ
J Alzheimers Dis; 2018; 66(1):407-419. PubMed ID: 30248055
[TBL] [Abstract][Full Text] [Related]
17. Adrenoceptors--classification, activation and blockade by drugs.
Andersson KE
Postgrad Med J; 1980; 56 Suppl 2():7-16. PubMed ID: 6107901
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Anagnostou E
Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748
[TBL] [Abstract][Full Text] [Related]
19. Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5.
Grzadzinski R; Dick C; Lord C; Bishop S
Mol Autism; 2016; 7():7. PubMed ID: 26788284
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice.
Jayaprakash P; Isaev D; Shabbir W; Lorke DE; Sadek B; Oz M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
